Detalles de la búsqueda
1.
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.
Proc Natl Acad Sci U S A
; 116(52): 26823-26834, 2019 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826955
2.
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.
Breast Cancer Res Treat
; 170(2): 279-292, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574636
3.
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer.
Cell Rep
; 42(8): 112821, 2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467106
4.
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.
Cell Rep
; 38(8): 110417, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196489
5.
Integrative clinical and molecular characterization of translocation renal cell carcinoma.
Cell Rep
; 38(1): 110190, 2022 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986355
6.
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models.
NPJ Breast Cancer
; 7(1): 63, 2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34045483
7.
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Clin Cancer Res
; 27(17): 4870-4882, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536276
8.
Towards personalized treatment for early stage HER2-positive breast cancer.
Nat Rev Clin Oncol
; 17(4): 233-250, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31836877
9.
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.
Clin Cancer Res
; 26(3): 738-745, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31653641
10.
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer.
Mol Cancer Res
; 17(11): 2318-2330, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420371
11.
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.
Clin Cancer Res
; 23(17): 5123-5134, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28487443
12.
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer.
Oncotarget
; 7(31): 50437-50449, 2016 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27391340
13.
Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Clin Cancer Res
; 27(17): 4939, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34470810
Resultados
1 -
13
de 13
1
Próxima >
>>